Taiwan · Delayed Price · Currency is TWD Hantech Bio-Technology Statistics
Total Valuation
TPEX:1294 has a market cap or net worth of TWD 2.14 billion. The enterprise value is 1.91 billion.
| Market Cap | 2.14B |
| Enterprise Value | 1.91B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Jul 3, 2026 |
Share Statistics
TPEX:1294 has 36.33 million shares outstanding. The number of shares has increased by 2.88% in one year.
| Current Share Class | 36.33M |
| Shares Outstanding | 36.33M |
| Shares Change (YoY) | +2.88% |
| Shares Change (QoQ) | -1.20% |
| Owned by Insiders (%) | 29.56% |
| Owned by Institutions (%) | n/a |
| Float | 15.62M |
Valuation Ratios
The trailing PE ratio is 14.48.
| PE Ratio | 14.48 |
| Forward PE | n/a |
| PS Ratio | 2.58 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | 14.17 |
| P/OCF Ratio | 12.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.68, with an EV/FCF ratio of 12.59.
| EV / Earnings | 12.73 |
| EV / Sales | 2.29 |
| EV / EBITDA | 8.68 |
| EV / EBIT | 10.35 |
| EV / FCF | 12.59 |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.71 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.51 |
| Debt / FCF | 0.75 |
| Interest Coverage | 66.46 |
Financial Efficiency
Return on equity (ROE) is 17.61% and return on invested capital (ROIC) is 24.03%.
| Return on Equity (ROE) | 17.61% |
| Return on Assets (ROA) | 9.82% |
| Return on Invested Capital (ROIC) | 24.03% |
| Return on Capital Employed (ROCE) | 18.99% |
| Weighted Average Cost of Capital (WACC) | 2.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 152 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 5.22 |
Taxes
In the past 12 months, TPEX:1294 has paid 35.26 million in taxes.
| Income Tax | 35.26M |
| Effective Tax Rate | 19.07% |
Stock Price Statistics
The stock price has increased by +8.70% in the last 52 weeks. The beta is -0.33, so TPEX:1294's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | +8.70% |
| 50-Day Moving Average | 64.96 |
| 200-Day Moving Average | 65.76 |
| Relative Strength Index (RSI) | 29.80 |
| Average Volume (20 Days) | 135,655 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1294 had revenue of TWD 831.92 million and earned 149.62 million in profits. Earnings per share was 4.07.
| Revenue | 831.92M |
| Gross Profit | 307.55M |
| Operating Income | 184.03M |
| Pretax Income | 184.91M |
| Net Income | 149.62M |
| EBITDA | 212.32M |
| EBIT | 184.03M |
| Earnings Per Share (EPS) | 4.07 |
Balance Sheet
The company has 354.30 million in cash and 112.97 million in debt, with a net cash position of 241.33 million or 6.64 per share.
| Cash & Cash Equivalents | 354.30M |
| Total Debt | 112.97M |
| Net Cash | 241.33M |
| Net Cash Per Share | 6.64 |
| Equity (Book Value) | 874.98M |
| Book Value Per Share | 24.00 |
| Working Capital | 383.36M |
Cash Flow
In the last 12 months, operating cash flow was 166.80 million and capital expenditures -15.52 million, giving a free cash flow of 151.28 million.
| Operating Cash Flow | 166.80M |
| Capital Expenditures | -15.52M |
| Depreciation & Amortization | 28.29M |
| Net Borrowing | -58.10M |
| Free Cash Flow | 151.28M |
| FCF Per Share | 4.16 |
Margins
Gross margin is 36.97%, with operating and profit margins of 22.12% and 17.98%.
| Gross Margin | 36.97% |
| Operating Margin | 22.12% |
| Pretax Margin | 22.23% |
| Profit Margin | 17.98% |
| EBITDA Margin | 25.52% |
| EBIT Margin | 22.12% |
| FCF Margin | 18.18% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 4.28%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 4.28% |
| Dividend Growth (YoY) | 26.61% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 58.44% |
| Buyback Yield | -2.88% |
| Shareholder Yield | 1.32% |
| Earnings Yield | 6.98% |
| FCF Yield | 7.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 3, 2026. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 3, 2026 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
TPEX:1294 has an Altman Z-Score of 6.29 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.29 |
| Piotroski F-Score | 6 |